18. Spinocerebellar degeneration Clinical trials / Disease details


Clinical trials : 71 Drugs : 99 - (DrugBank : 30) / Drug target genes : 45 - Drug target pathways : 65

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00034242
(ClinicalTrials.gov)
April 200224/4/2002High-Dose Intravenous Immunoglobulin to Treat Cerebellar DegenerationThe Efficacy of High-Dose Intravenous Immunoglobulin Therapy In Patients With Cerebellar Degeneration: A Double Blind, Placebo Controlled TrialSpinocerebellar DegenerationsDrug: high-dose intravenous immunoglobulin (IVIG)National Institute of Neurological Disorders and Stroke (NINDS)NULLCompletedN/AN/ABoth20Phase 2United States